Hand Grip Strength Index, a Novel Tool in Risk-Assessing Multi-Ethnic End-Stage Kidney Disease Patients Treated by Haemodialysis

握力指数:一种用于评估接受血液透析治疗的多民族终末期肾病患者风险的新工具

阅读:1

Abstract

INTRODUCTION: Increasing numbers of elderly co-morbid patients with end-stage kidney disease (ESKD) are now offered haemodialysis. Simple, rapid screening tools are required to risk-assess patients, highlighting those requiring nutritional or other support and advising on prognosis. As such, we assessed a newly introduced tool, the hand grip strength index (HGS index), a comparison of measured to predicted HGS. METHODS: We reviewed ESKD dialysis patients dialysing under the care of an inner-city tertiary dialysis centre who had contemporaneous HGS measurements, and body composition measured by multifrequency bioelectrical impedance analysis, followed for ≤ 9 years, censoring for transplantation. RESULTS: Results from 1023 patients, 63.2% male, 48.2% White and 46.5% diabetic, with a dialysis vintage of 21.2 (7.2-61.0) months, were analysed. Mortality was significantly greater for those in the lowest HGS index quartile using Kaplan-Meier analysis (p < 0.001). On multivariable step-backward Cox regression analysis, mortality was independently significantly associated (p < 0.001) with increasing age (hazard ratio [HR] 1.04 95% confidence interval (CI) [1.029-1.045]), higher co-morbidity score (HR 1.24 [1.142-1.347]) and post-dialysis extracellular water/total body water ratio (HR 1.15 [1.089-1.219]) and lower HGS index (HR -0.76 [0.991-0.998]), whereas sarcopenia and frailty were not retained in the model. CONCLUSION: Increasing numbers of elderly co-morbid patients are being treated with dialysis, so simple screening tools are required to advise on prognosis and highlight patients who may need additional support, including nutrition. We found the HGS index to have prognostic value, along with the traditional risk factors of patient age and co-morbidity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。